Literature DB >> 31132732

Sodium tanshinone IIA sulfonate inhibits proliferation, migration, invasion and inflammation in rheumatoid arthritis fibroblast-like synoviocytes.

Zeyu Wang1, Jinglong Li1, Jun Zhang1, Xuhua Xie2.   

Abstract

Our study aimed to determine the effects of sodium tanshinone IIA sulfonate (STS) on proliferation, migration, invasion, and inflammation in rheumatoid arthritis human fibroblast-like synoviocytes (RA-HFLSs). Firstly, results demonstrated STS reduced proliferation, migration, invasion in HFLSs. Also, we found that STS could alleviate the reorganizations of F-actin cytoskeleton in TNF-α-treated HFLSs. In addition, STS decreased the production of IL-1β, IL-6, MMP-1, and MMP-3 in TNF-α-treated RA-HFLSs. Further study showed that STS blocked MAPK/NF-κB activations in TNF-α-stimulated RA-HFLSs. Moreover, we illustrated that STS could alleviate rheumatoid arthritis progression and prevent inflammation damage in joint tissues of collagen-induced arthritis (CIA) mice. Taken together, this study suggested that STS inhibited proliferation, migration, invasion, and inflammation of RA-HFLSs by blocking MAPK/NF-κB pathways.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibroblast-like synoviocytes rheumatoid arthritis; Inflammation; MAPK/NF-κB pathway; Migration; Proliferation; Sodium tanshinone IIA sulfonate

Mesh:

Substances:

Year:  2019        PMID: 31132732     DOI: 10.1016/j.intimp.2019.05.023

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  The enzymatic poly(gallic acid) reduces pro-inflammatory cytokines in vitro, a potential application in inflammatory diseases.

Authors:  Yessica Zamudio-Cuevas; Marco A Andonegui-Elguera; Ariadna Aparicio-Juárez; Edson Aguillón-Solís; Karina Martínez-Flores; Erika Ruvalcaba-Paredes; Cristina Velasquillo-Martínez; Clemente Ibarra; Valentín Martínez-López; Marwin Gutiérrez; Roeb García-Arrazola; Carmen G Hernández-Valencia; Alejandra Romero-Montero; Miguel A Hernández-Valdepeña; Miquel Gimeno; Roberto Sánchez-Sánchez
Journal:  Inflammation       Date:  2021-02       Impact factor: 4.092

2.  Silencing long non-coding RNA NEAT1 attenuates rheumatoid arthritis via the MAPK/ERK signalling pathway by downregulating microRNA-129 and microRNA-204.

Authors:  Jie Chen; Xiao Luo; Mao Liu; Lihui Peng; Zixia Zhao; Chengsong He; Yue He
Journal:  RNA Biol       Date:  2021-01-20       Impact factor: 4.652

3.  Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis.

Authors:  Ye Gong; Ya-Ling Zhang; Zhen Wang; Huan-Huan Song; Yuan-Chu Liu; Ao-Wei Lv; Li-Li Tian; Wen-Li Zhu; Ying Fu; Xiao-Li Ding; Lang-Jun Cui; Ya-Ping Yan
Journal:  J Neuroinflammation       Date:  2020-06-25       Impact factor: 8.322

4.  Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension.

Authors:  Ya-Ru Bao; Jing-Wei Chen; Yan Jiang; Lin-Hui Wang; Rong Xue; Jin-Xian Qian; Guo-Xing Zhang
Journal:  Front Pharmacol       Date:  2020-05-21       Impact factor: 5.810

Review 5.  Practical Implementation of Artificial Intelligence-Based Deep Learning and Cloud Computing on the Application of Traditional Medicine and Western Medicine in the Diagnosis and Treatment of Rheumatoid Arthritis.

Authors:  Shaohui Wang; Ya Hou; Xuanhao Li; Xianli Meng; Yi Zhang; Xiaobo Wang
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

6.  Efficacy and Safety of Tanshinone for Chronic Kidney Disease: A Meta-Analysis.

Authors:  Yao Zhou; Shi-Min Jiang; Li Li; Ying Wang; Lei Ding; Chao-Xia Liu; Qi Wu; Kun Gao
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-13       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.